Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals

Abstract Background To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic markers of future cognitive decline in older adults with and without cognitive impairment. Methods In this longitudinal study, we included 396 cognitively normal to dementia subjects with 18...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Davina Biel, Matthias Brendel, Anna Rubinski, Katharina Buerger, Daniel Janowitz, Martin Dichgans, Nicolai Franzmeier, for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-08-01
Edice:	Alzheimer’s Research & Therapy
Témata:	Alzheimer’s disease Braak-staging Tau-PET Amyloid-PET Conversion risk
On-line přístup:	https://doi.org/10.1186/s13195-021-00880-x
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!